
UK network to support innovation within advanced therapies
A new network aspires to create a world-leading regulatory environment in the UK for advanced therapies that supports companies in the development, trial, and launch of these treatments. Cell and Gene Therapy Catapult (CGT Catapult) and the Birmingham Health Partners Centre for Regulatory Science and Innovation (CRSI)… Read More















